The TZ-PD trial will be a 1:1 (active:placebo) randomized, double-blind, placebo-controlled Phase II trial to evaluate the safety and tolerability of terazosin for the treatment of PD.
New clinical trial: Terazosin for Parkins... - Cure Parkinson's
New clinical trial: Terazosin for Parkinson's Disease (TZ-PD) April 5, 2019
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Allopregnanolone as a Regenerative Treatment for Parkinson's Disease (Allo-PD)
PD.
Secondary Objectives: To evaluate the safety and tolerability of weekly infusions of Allo in...
New and current hope for Parkinson's Disease
the PD. It seems that most of the real successful trials are either very limited or over in other...
Parkinson's Disease Clinical trial for First in Humans use of FGF-1 to treat Parkinson's Disease started by Zhittya Genesis Medicine.
start the First in Humans Proof of Concept-Phase I clinical trial to treat Parkinson's. Daniel...
Clinical trial suggests Parkinson's drug is safe in humans
inhibitor called DNL201 showed no ill effects to volunteers in a clinical trial. The researchers...
Related Posts
Parkinson's Drug Reduces Disease Markers in Breakthrough Trial
MSC clinical trials to treat Parkinson's disease
Trehalose as a promising therapeutic candidate for the treatment of Parkinson's disease - 2019
The Effect of Curcumin on Idiopathic Parkinson Disease: A Clinical and Skin Biopsy Study- Clinical trial for new stem cell-based treatment for Parkinson’s disease given go ahead
